12.29  -0.87 (-6.61%)		10-16 16:00
Open: 13.24 High: 13.3 Volume: 778,682		Pre. Close: 13.16 Low: 12.1636 Market Cap: 1,137(M)

Short term
Mid term
Targets	6-month :	16.82	1-year :	18.44
Resists	First :	14.4	Second :	15.78
Pivot price	14.22
Supports	First :	12.16	Second :	10.12
MAs	MA(5) :	13.39	MA(20) :	14.39
	MA(100) :	12.92	MA(250) :	9.04
MACD	MACD :	-0.4	Signal :	-0.2
%K %D	K(14,3) :	4.9	D(3) :	9.7
RSI	RSI(14): 29
52-week	High :	15.78	Low :	3.43

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ DRTS ] has closed below the lower bollinger band by 13.7%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 22.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	13.39 - 13.52	13.52 - 13.59
Low:	11.91 - 12.06	12.06 - 12.16
Close:	12.11 - 12.37	12.37 - 12.52

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Mon, 31 Aug 2026
Alpha Tau Medical (DRTS) finishes pancreatic IMPACT study signup - Stock Titan

Fri, 21 Aug 2026
Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan - Stock Titan

Mon, 10 Aug 2026
Alpha Tau Medical (NASDAQ: DRTS) moves to dual-list shares on TASE - Stock Titan

Mon, 10 Aug 2026
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - Alpha Tau Medical

Mon, 10 Aug 2026
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update - Alpha Tau Medical

Fri, 31 Jul 2026
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	92 (M)
Shares Float	64 (M)
Held by Insiders	30.5 (%)
Held by Institutions	9.2 (%)
Shares Short	3,450 (K)
Shares Short P.Month	3,090 (K)

EPS	-1.04
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.47
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-25.8 %
Return on Equity (ttm)	-141.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.53
Qtrly Earnings Growth	0 %
Operating Cash Flow	-13 (M)
Levered Free Cash Flow	-20 (M)

PE Ratio	-11.82
PEG Ratio	0
Price to Book value	25.6
Price to Sales	0
Price to Cash Flow	-88.73

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.